HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

eosinylphosphatidylethanolamine (EOPE)

probe of interfacial pH
Also Known As:
EOPE; eosinyl-sn-glycero-3-phosphoethanolamine
Networked: 98 relevant articles (1 outcomes, 23 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Herzog, Emilie M: 4 articles (01/2019 - 01/2016)
2. Aslan Cetin, Berna: 3 articles (06/2020 - 11/2018)
3. Steegers, Eric A P: 3 articles (01/2019 - 01/2016)
4. Willemsen, Sten P: 3 articles (01/2019 - 01/2016)
5. Eggink, Alex J: 3 articles (10/2017 - 01/2016)
6. Conceição, Izabela M C A: 2 articles (01/2022 - 11/2020)
7. Cruz, Juliana de O: 2 articles (01/2022 - 11/2020)
8. Luizon, Marcelo R: 2 articles (01/2022 - 11/2020)
9. Marín, Reinaldo: 2 articles (01/2022 - 12/2020)
10. Rojas, Deliana: 2 articles (01/2022 - 12/2020)

Related Diseases

1. Pre-Eclampsia (Preeclampsia)
2. Fetal Growth Retardation (Intrauterine Growth Retardation)
01/01/2019 - "Placental tissue of 11 early onset PE (EOPE), 11 late onset PE (LOPE) and 60 controls consisting of 25 uncomplicated controls 20 fetal growth restriction (FGR) and 15 preterm births (PTB) controls was collected from a nested case-control study of The Rotterdam Periconceptional Cohort. "
01/01/2017 - "We performed a nested case-control study in The Rotterdam Periconceptional Cohort, including 30 PE pregnancies (15 EOPE, 15 LOPE) and 218 control pregnancies (164 uncomplicated controls, 54 complicated controls including 28 fetal growth restriction, 26 preterm birth) and assessed macroscopic and histomorphometric outcomes of the placenta and umbilical cord. "
01/01/2016 - "A secondary cohort analysis in The Rotterdam Periconceptional Cohort was conducted comprising 23 PE cases, including 11 EOPE and 12 LOPE, and 195 controls, including 153 uncomplicated and 23 fetal growth restriction- and 19 preterm birth complicated controls. "
03/17/2023 - "This study aimed to investigate the association of the epithelial and lymphoid immune markers with the adverse perinatal conditions such as early-onset preeclampsia (EOPE), fetal growth restriction (FGR) and intrauterine fetal death (IUFD) in preeclampsia in the placentae of preeclamptic patients. "
10/01/2019 - "Goal: Our aim was to determine whether alterations in serum serglycin and agrin levels in early-onset preeclampsia (EOPE) are useful in predicting adverse perinatal outcomes such as fetal growth restriction (FGR), intrauterine fetal demise (IUFD), preterm delivery and/or neonatal unit admission. "
3. Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
4. Hypoxia (Hypoxemia)
5. Fetal Death

Related Drugs and Biologics

1. Intercellular Signaling Peptides and Proteins (Growth Factors)
2. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
3. Pregnancy-Associated Plasma Protein-A (PAPP-A)
4. Chorionic Gonadotropin (Human Chorionic Gonadotropin)
5. alpha-Fetoproteins (alpha-Fetoprotein)
6. Biomarkers (Surrogate Marker)
7. Proteins (Proteins, Gene)
8. MicroRNAs (MicroRNA)
9. Long Noncoding RNA
10. Toll-Like Receptors (Toll-Like Receptor)

Related Therapies and Procedures

1. Immunomodulation
2. Highly Active Antiretroviral Therapy (HAART)
3. Prenatal Care (Care, Prenatal)
4. Blood Component Removal (Apheresis)